These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 1712710)

  • 1. Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease.
    Deget F; Brogden RN
    Drugs; 1991 May; 41(5):799-820. PubMed ID: 1712710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders.
    Todd PA; Benfield P
    Drugs; 1990 Jan; 39(1):110-35. PubMed ID: 2138076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilazapril. A review.
    Szucs T
    Drugs; 1991; 41 Suppl 1():18-24. PubMed ID: 1712267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of cilazapril.
    Kleinbloesem CH; van Brummelen P; Francis RJ; Wiegand UW
    Drugs; 1991; 41 Suppl 1():3-10. PubMed ID: 1712269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and effects on renal function following cilazapril and hydrochlorothiazide alone and in combination in healthy subjects and hypertensive patients.
    Nilsen OG; Sellevold OF; Romfo OS; Smedsrud A; Grynne B; Williams PE; Kleinbloesem CH
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):323S-328S. PubMed ID: 2527546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of cilazapril.
    Kleinbloesem CH; Van Brummelen P; Francis RJ; Wiegand UW
    Am J Med; 1989 Dec; 87(6B):45S-49S. PubMed ID: 2532460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ramipril: a review of the new ACE inhibitor.
    Mills TP
    J Ark Med Soc; 1992 Feb; 88(9):437-40. PubMed ID: 1532570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilazapril: an overview of its efficacy and safety in hypertension.
    Szucs T; Schneeweiss A
    Cardiology; 1992; 80(1):34-41. PubMed ID: 1532534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor.
    Waterfall JF
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):139S-150S. PubMed ID: 2527528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacodynamic studies with cilazapril and a combination of cilazapril and propranolol.
    Erb KA; Essig J; Breithaupt K; Belz GG
    Drugs; 1991; 41 Suppl 1():11-7. PubMed ID: 1712266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilazapril: a new non-thiol-containing angiotensin-converting enzyme inhibitor. Worldwide clinical experience in hypertension.
    Kögler P
    Am J Med; 1989 Dec; 87(6B):50S-55S. PubMed ID: 2532461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders.
    Todd PA; Fitton A
    Drugs; 1991 Jul; 42(1):90-114. PubMed ID: 1718688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic interactions between the ACE inhibitor cilazapril and beta-adrenoceptor antagonist propranolol in healthy subjects and in hypertensive patients.
    Belz GG; Essig J; Erb K; Breithaupt K; Hoogkamer JF; Kneer J; Kleinbloesem CH
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):317S-322S. PubMed ID: 2527545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological properties of the angiotensin-converting enzyme inhibitor cilazapril.
    Natoff IL; Nixon JS; Francis RJ; Klevans LR; Brewster M; Budd J; Patel AT; Wenger J; Worth E
    J Cardiovasc Pharmacol; 1985; 7(3):569-80. PubMed ID: 2410692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.
    Lancaster SG; Todd PA
    Drugs; 1988 Jun; 35(6):646-69. PubMed ID: 2844497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure.
    Balfour JA; Goa KL
    Drugs; 1991 Sep; 42(3):511-39. PubMed ID: 1720384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
    Essig J; Belz GG; Wellstein A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):217S-223S. PubMed ID: 2548551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics and angiotensin converting enzyme inhibition dynamics of cilazapril in essential hypertension.
    Meredith PA; Elliott HL; Reid JL; Francis RJ
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):263S-266S. PubMed ID: 2548553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive effects and pharmacokinetics of single and consecutive doses of cilazapril in hypertensive patients with normal or impaired renal function.
    Shionoiri H; Gotoh E; Sugimoto K; Takasaki I; Minamisawa K; Ishii M
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):283S-287S. PubMed ID: 2527540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.